SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer | stella

Back to Pancreatic Cancer trials

Completed

Plain-English translation of NCT02704156 on ClinicalTrials.gov ↗ · Source last updated May 2022 · How we translate trials

Read our Pancreatic cancer research guide →

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

China

Changhai hospital, Shanghai, Shanghai Municipality

Results

Read the full plain-English summary of this trial →

Key details

Phase

Testing effectiveness

Sponsor

Changhai Hospital

Enrollment target

~170 participants

Started

October 2016

Primary completion

December 2020

Age range

18 Years and older

Last updated on clinicaltrials.gov in May 2022.

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.